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Abstract
Background: Organs are programmed to acquire a particular size during development, but the
regulatory mechanisms that dictate when dividing progenitor cells should permanently exit the cell
cycle and stop producing additional daughter cells are poorly understood. In differentiated tissues,
tumor suppressor genes maintain a constant cell number and intact tissue architecture by
controlling proliferation, apoptosis and cell dispersal. Here we report a similar role for two tumor
suppressor genes, the Zac1 zinc finger transcription factor and that encoding the cytokine TGFβII,
in the developing retina.
Results: Using loss and gain-of-function approaches, we show that Zac1 is an essential negative
regulator of retinal size. Zac1 mutants develop hypercellular retinae due to increased progenitor
cell proliferation and reduced apoptosis at late developmental stages. Consequently,
supernumerary rod photoreceptors and amacrine cells are generated, the latter of which form an
ectopic cellular layer, while other retinal cells are present in their normal number and location.
Strikingly, Zac1 functions as a direct negative regulator of a rod fate, while acting cell non-
autonomously to modulate amacrine cell number. We implicate TGFβII, another tumor suppressor
and cytokine, as a Zac1-dependent amacrine cell negative feedback signal. TGFβII and phospho-
Smad2/3, its downstream effector, are expressed at reduced levels in Zac1 mutant retinae, and
exogenous TGFβII relieves the mutant amacrine cell phenotype. Moreover, treatment of wild-type
retinae with a soluble TGFβ inhibitor and TGFβ receptor II (TGFβRII) conditional mutants
generate excess amacrine cells, phenocopying the Zac1 mutant phenotype.
Conclusion: We show here that Zac1 has an essential role in cell number control during retinal
development, akin to its role in tumor surveillance in mature tissues. Furthermore, we
demonstrate that Zac1 employs a novel cell non-autonomous strategy to regulate amacrine cell
number, acting in cooperation with a second tumor suppressor gene, TGFβII, through a negative
feedback pathway. This raises the intriguing possibility that tumorigenicity may also be associated
with the loss of feedback inhibition in mature tissues.
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Tissues and organs are genetically programmed to achieve
their optimal, mature size, defined by total cell number
and individual cellular dimensions. Several regulatory
strategies are employed to control cell number, including:
direct negative regulators, which inhibit alternative cell
fates but permit (or instruct) a primary fate; negative feed-
back pathways, acting as cell sensors that halt the contin-
ued genesis of specific cell types once a feedback signal
reaches threshold levels; and cell counting mechanisms,
whereby the number of times a progenitor divides before
differentiating is genetically determined [1,2]. In the ver-
tebrate retina, negative feedback pathways are used recur-
rently for cell number control. The retina is composed of
one glial and six neuronal cell types that are present in
stereotyped proportions in each vertebrate species [3-5].
Based on lineage tracing, all retinal cell types are derived
from multipotent progenitor cells [6-11], although dis-
tinct cell lineages likely also exist [1,12]. In mouse, retinal
ganglion cells (RGCs), horizontal cells, cone photorecep-
tors and amacrine cells are primarily generated during the
second half of the embryonic period, while rod photo-
receptor, bipolar and Müller glial cell production ends on
postnatal days (P) 5–6 in the central retina [3]. Differenti-
ated RGCs, amacrine cells and cones secrete signals nega-
tively regulating production of additional cells of that type
[13-16]. However, only signals limiting production of
RGCs have been identified, including Sonic hedgehog
(Shh) and growth and differentiation factor-11 (GDF11)
[17]. GDF11, a transforming growth factor (TGF)β family
member, has similar autoregulatory functions in other tis-
sues, including the olfactory epithelium [18] and pancreas
[19], while a related molecule, GDF8 (myostatin), nega-
tively regulates skeletal muscle mass [20], suggesting a
common role for these cytokines in cell number control.
We identified Zac1 (zinc finger protein that regulates apopto-
sis and cell cycle arrest or pleiomorphic adenoma gene-like 1
(Plag-l1)) [21] in a screen designed to isolate genes
involved in neural fate specification [22]. Zac1 encodes a
seven-C2H2 zinc finger protein that acts as a transcrip-
tional activator or repressor [21]. Zac1 is a known tumor
suppressor gene and is frequently lost in multiple carcino-
mas [21]. Zac1 is also maternally repressed through
genomic imprinting, a mode of epigenetic control com-
mon to many genes regulating embryonic growth.
Recently, a Zac1 null mutation was shown to lead to intra-
uterine growth restriction, consistent with the kinship the-
ory that paternally expressed genes are growth promoting
[23]. However, growth retardation was not expected if
Zac1 has tumor suppressor properties, promoting cell
cycle exit and apoptosis [21,24]. We therefore examined
Zac1 function at the cellular level, focusing on the devel-
oping retina, where it is robustly expressed [25]. Notably,
in our initial cross-species studies in Xenopus, murine Zac1
unexpectedly promoted proliferation [26]. Herein we
describe intra-species loss- and gain-of-function assays in
mouse that in contrast reveal tumor suppressor-like prop-
erties for Zac1 in the retina. Zac1 is required to induce cell
cycle exit and apoptosis at late developmental stages, with
Zac1 mutant retinae becoming hypercellular, containing
supernumary rod photoreceptors and amacrine cells.
Strikingly, Zac1 negatively regulates rod and amacrine cell
numbers through distinct autonomous and cell non-
autonomous (TGFβII-mediated) inhibitory mechanisms,
respectively.
Results
Biphasic expression of Zac1 in retinal progenitors and 
postmitotic cells
We identified Zac1 in a subtractive screen designed to
identify regulators of neuronal fate specification [22]. In
an initial expression survey, we noted high Zac1 expres-
sion in the developing retina [25]. A detailed spatiotem-
poral characterization from embryonic day (E) 10.5
through P0 revealed high levels of Zac1 transcripts (Figure
1a–d) and protein (Figure 1f–i) in the outer neuroblast
layer (onbl), where proliferating progenitors reside, and
not in the inner neuroblast layer (inbl) of postmitotic
cells that, prior to P0, primarily includes RGCs and ama-
crine cells (Additional data file 1 (a–c)). Confirming Zac1
expression in dividing cells, a large number of Zac1+ cells
incorporated the S-phase label bromodeoxyuridine
(BrdU) after a 30 minute pulse at E15.5 (Additional data
file 1 (d–f)). Notably, Zac1 expression declined in central,
more mature retinal progenitors by P0 (Figure 1d, i).
At P2 (not shown), P7 (Figure 1e, j) and P21 (Additional
data file 1 (g,h)), Zac1 transcripts and protein were
detected in scattered postmitotic cells in the inner nuclear
layer (INL) and RGC layer (GCL; Figure 1k–o). Double
immunolabeling with cell type-specific markers at P7
revealed Zac1 expression in CRALBP+ Müller glia (64.1%
± 6.26% Zac1+cells; n = 3 retinae; Figure 1k,k'), syntaxin+
(not shown) and Pax6+ amacrine cells (17.5% ± 3.6%; Fig-
ure 1m,m'), Brn3a+ RGCs (17.2% ± 5.0%; Figure 1o,o')
and calbindin+ horizontal cells (1.2% ± 0.7%; Figure
1l,l'). Zac1 was not detected in protein kinase C (PKC)-
expressing bipolar cells (Figure 1n,n') or in rod and cone
photoreceptors in the outer nuclear layer (ONL).
Zac1 is thus expressed biphasically in the retina, initially
in dividing retinal progenitors and later in Müller glia,
RGCs, amacrine and horizontal cells.
Zac1 mutants develop hypercellular retinae containing an 
ectopic cellular layer
To investigate the in vivo requirement for Zac1, we ana-
lyzed embryos with a Zac1 null allele [23]. Because Zac1
is maternally imprinted, Zac1+m/- heterozygotes inherit-Page 2 of 21
(page number not for citation purposes)
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11ing a wild-type allele from their mother are effectively
mutant for Zac1. Indeed, imprinting occurs in the gam-
etes, and complete methylation of Zac1 is achieved in
96.8% of mature oocytes [27]. Accordingly, Zac1+m/- ret-
inae were devoid of Zac1 immunolabeling (Additional
data file 2) and were thus considered equivalent to null
mutants throughout this study.
By P3, 80% of Zac1+m/- pups die, with 50% dying within
the first 24 hours [23]. To ensure we did not analyze sur-
Biphasic Zac1 expression in the retinaF gure 1
Biphasic Zac1 expression in the retina. Zac1 (a-e) transcript and protein (f-j) distribution from E10.5 to P7. Arrowheads in 
(d,g,i) mark limits of higher expression domains. (k-o) Identification of Zac1+ P7 retinal cells. Co-labeling with Zac1 (red) and 
CRALBP (green (k,k')), calbindin (green (l,l')), Pax6 (green (m,m')), PKC (green (n,n')) and Brn3a (green (o,o')). High mag-
nification images of boxed areas are shown in (k'-o'). Arrowheads mark double+ cells. Of 2,154 Zac1+ cells analyzed, 1,238 
CRALBP/Zac1 double+ Müller glia; 29 calbindin/Zac1 double+ horizontal cells (based also on morphology), 480 Pax6/Zac1 dou-
ble+ amacrine cells (in the INL) and 407 Brn3a/Zac1 double+ RGCs were identified. GCL, ganglion cell layer; inbl, inner neurob-
last layer; INL, inner nuclear layer; le, lens; lv, lens vesicle; onbl, outer neuroblast layer; ONL, outer nuclear layer; ov, optic 
vesicle.Page 3 of 21
(page number not for citation purposes)
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11viving pups with unknown compensatory mechanisms,
we studied only Zac1+m/- embryos collected prenatally,
when Mendelian ratios of mutants were obtained. To cir-
cumvent the problem of retinogenesis not being complete
until about P5–6 in the central retina [3], we cultured
E18.5 retinae as explants for eight days in vitro (DIV),
recapitulating the normal histogenic process [28]. Subse-
quent phenotypic analyses then focused on the central ret-
ina, adjacent to the transected optic nerve, where
differentiation was complete. Strikingly, most Zac1+m/-
explants (55%; n = 27/49) were thicker than their litter-
mate controls, developing a distinct, ectopic cellular layer
(ECL) between the INL and GCL (Figure 2b,d,f,f',h,h';
Additional data file 3). Wild-type (Figure 2a,c,e,e',g,g')
and remaining Zac1+m/- retinae (not shown) acquired a
normal trilaminar structure.
An ECL may develop due to an overall increase in retinal
cell number and/or aberrant cellular migration. To deter-
mine if Zac1+m/- retinae were hypercellular, DAPI-
labeled nuclei were counted. In ECL-containing Zac1+m/
- explants (hereafter designated Zac1+m/-+ECL), there
was a 1.34-fold increase in the number of INL cells (p <
0.001; 442.9 ± 17.9 cells/field; n = 9 retinae) compared to
wild-type controls (329.5 ± 22.0 cells/field; n = 10) or
non-ECL containing mutants (henceforth simply desig-
nated Zac1+m/-; 314.0 ± 22.1 cells/field; n = 3; Figure 2i).
Strikingly, Zac1+m/-+ECL retinae also exhibited a 1.23-
fold increase in ONL cells (p < 0.01; 969.4 ± 46.1 cells/
field; n = 9) compared to wild-type controls (790.3 ± 40.7
cells/field; n = 10) or Zac1+m/- (735 ± 106.7 cells/field; n
= 3; Figure 2i). In contrast, cellular contents of the GCL
were comparable in wild-type (59.2 ± 3.1 cells/field; n =
10), Zac1+m/-+ECL (62.0 ± 4.3 cells/field; n = 9) and
Zac1+m/- (55.3 ± 1.8 cells/field; n = 3) explants. Zac1 is,
therefore, an essential negative regulator of retinal cell
number and is also required to orchestrate appropriate
cellular migration.
The Zac1+m/- ECL is composed of supernumerary amacrine 
cells
To identify the expanded cell population(s) in Zac1+m/-
+ECL retinae, E18.5→8DIV explants were immunos-
tained with cell type-specific markers. Strikingly, almost
all cells in the Zac1+m/- ECL expressed the homeodomain
transcription factor Pax6 (Figure 2f,f'), which was also
expressed by amacrine cells in the INL and GCL in wild-
type (Figure 2e,e',f,f') and Zac1+m/- (data not shown)
E18.5→8DIV explants. Although Pax6 labels both ama-
crine cells and RGCs [29], RGCs rapidly undergo apopto-
sis following optic nerve transection (in explants [30]),
allowing us to assign an amacrine cell identity to ECL
cells. Accordingly, no other RGC markers (Brn3a/3b,
Thy1.2; not shown) were detected in the ECL or GCL of
wild-type or Zac1+m/-+ECL explants. Moreover, RGC dif-
ferentiation is essentially complete by E18.5, and at this
stage, equivalent numbers of RGCs were labeled by Brn3a
(p = 0.95) and Brn3b (p = 0.23) in wild-type and Zac1+m/-
retinae, indicating Zac1 does not regulate RGC number (n
= 3 for each; total n = 6; Additional data file 4). Further-
more, syntaxin, which labels amacrine cell membranes
and processes in the inner plexiform layer (IPL; Figure
2g,g'), marked duplicated and disorganized synaptic plexi
(IPL/IPL') in Zac1+m/-+ECL explants (Figure 2h,h').
Finally, amacrine cell subtype markers, including Bhlhb5,
calbindin, GABA and the GlyT1 glycine transporter, were
all expressed in Zac1+m/- ECL (Additional data file 3 (k–
p)).
Quantitation of Pax6+ nuclei in E18.5→8DIV explants
revealed a 1.31-fold increase (p < 0.01) in the percentage
of amacrine cells in Zac1+m/-+ECL retinae, while Zac1+m/-
explants contained wild-type proportions of these
interneurons (wild type: 15.1 ± 0.5%; n = 4; Zac1+m/-: 15.2
± 1.3%; n = 3; Zac1+m/-+ECL: 19.8 ± 1.3%; n = 3; Figure
2j). In contrast, all other INL cell types were present at
equivalent ratios in wild-type and Zac1+m/-+/-ECL retinae,
including bipolar cells (Chx10+; wild type: 8.7 ± 0.6%; n
= 4; Zac1+m/-: 10.5 ± 0.9%; n = 3; Zac1+m/-+ECL: 7.2 ±
1.3%; n = 3), Müller glia (CRALBP+: wild type: 5.2 ± 0.3%;
n = 4; Zac1+m/-: 4.3 ± 0.2%; n = 3; Zac1+m/-+ECL: 3.9 ±
0.5%; n = 3; p27Kip1+: wild type: 5.9 ± 0.5%; n = 4; Zac1+m/
-: 5.1 ± 0.7%; n = 3; Zac1+m/-+ECL: 5.8 ± 0.1%; n = 3) and
horizontal cells (calbindin+; identified also by morphol-
ogy and apical location; wild type: 1.1 ± 0.3%; n = 3;
Zac1+m/-: 0.8 ± 0.2%; n = 4; Zac1+m/-+ECL: 0.1 ± 0.1%; n =
3; Figure 2j; Additional data file 3 (m,n)).
Cones normally comprise only 3% of the murine photo-
receptor pool [31]. In Zac1+m/-+ECL and wild-type retinae,
similar numbers of cones were labeled with peanut agglu-
tinin (PNA; p = 0.26; wild type: 50.4 ± 1.2cells/field; n =
3; Zac1+m/-+ECL: 64.6 ± 10.1cells/field; n = 3) and s-opsin
(p = 0.70; wild type: 44.22 ± 8.91cells/field; n = 3; Zac1+m/
-+ECL: 39.75 ± 6.66cells/field; n = 4; Additional data file
3 (g–j)). Instead, the vast majority of ONL cells in wild-
type and Zac1+m/-+ECL explants expressed the rod-specific
markers rhodopsin (Figure 2c, d) and Nr2e3 (not shown),
indicating that the rod pool is expanded in Zac1+m/-+ECL
retinae. Zac1 therefore ensures appropriate numbers of
rod photoreceptors and amacrine cells are generated dur-
ing development.
Retinal progenitors divide ectopically in Zac1 mutants late 
in retinogenesis
The hypercellularity of Zac1+m/- retinae could arise due to
additional rounds of cell division and/or a reduction in
apoptosis. To determine if cell cycle exit was perturbed, S-
phase progenitors were BrdU pulse-labeled 30 minutes
prior to sacrifice. During embryogenesis (E13.5-E18.5)Page 4 of 21
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Zac1+m/- retinae develop an ectopic amacrine cell layer and supernumerary rod photoreceptorsFigure 2
Zac1+m/- retinae develop an ectopic amacrine cell layer and supernumerary rod photoreceptors. (a-h) E18.5→8DIV retinal 
explants. DAPI-stained (a) wild-type and (b) Zac1+m/- explants. Rhodopsin expression in (c) wild-type and (d) Zac1+m/-+ ECL 
retinae. (e,e',f,f') Pax6 and (g,g',h,h') syntaxin expression in amacrine cells in wild-type (e,e',g,g') and Zac1+m/-+ECL (f,f',h,h') 
retinae. Asterisks mark the ECL. The duplicated IPL is labeled by ipl' in (h'). Blue is DAPI counterstain. (i) Average of the abso-
lute number of DAPI+ nuclei/layer in a standard counting field in wild-type (black bar; total DAPI+ nuclei counted in 30 fields; 
ONL: 23,700; INL: 9,870; GCL: 1,776), Zac1+m/- without an ECL (grey bar; total DAPI+ nuclei counted in 9 fields; ONL: 6,615; 
INL: 2,826; GCL: 498 nuclei) and Zac1+m/-+ECL (white bar; total DAPI+ nuclei counted in 27 fields; ONL: 26,175; INL: 11,968; 
GCL: 1,674). (j) Percentage of each retinal cell type based on total cell counts in wild-type (black bar; HC: 56 calbindin+/7,183 
DAPI+; AC: 1,832 Pax6+/11,696 DAPI+; BP: 819 Chx10+/9,302 DAPI+; MG: 1,003 p27+/18,465 DAPI+ nuclei; 537 CRALBP+/
9,169 DAPI+), Zac1+m/- without an ECL (grey bar; HC: 64 calbindin+/12,960 DAPI+; AC: 1,558 Pax6+/10,304 DAPI+; BP: 1,077 
Chx10+/10,171 DAPI+; MG: 430 p27+/9,966 DAPI+; 332 CRALBP+/6,773 DAPI+) and Zac1+m/-+ECL retinae (white bar; HC: 11 
calbindin+/1,924 DAPI+; AC: 2,068 Pax6+/11,302 DAPI+; BP: 646 Chx10+/9,157 DAPI+; MG: 395 p27+/9,921 DAPI+; 240 
CRALBP+/3,319 DAPI+). AC, amacrine cell; BP, bipolar cell; HC, horizontal cell; MG, Müller glia.
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11and in E18.5→2DIV explants, BrdU-labeling indices were
similar in wild-type and Zac1+m/- retinae (Figure 3e). In
contrast, in E18.5→4DIV Zac1+m/- explants, BrdU incor-
poration was elevated 2.1-fold over wild type (p < 0.002;
Zac1+m/-: 3.4 ± 0.4%; n = 10; wild type: 1.6 ± 0.3%; n =
7; Figure 3a,b,e), although an ECL was not yet distinguish-
able. Notably, BrdU-labeling indices were variable in indi-
vidual Zac1+m/- retinae, with about 50% of the mutant
explants well above wild-type values (Figure 3f), a pheno-
typic distribution corresponding well with the proportion
of mutant explants that later developed a hypercellular
phenotype (see above). Furthermore, in 6DIV explants,
when cell division had ceased in wild-type central retinae,
BrdU uptake persisted in some mutants (p < 0.05; 0.5 ±
0.01%; n = 4/11; Figure 3c–e). As an independent cell
cycle parameter, cyclin D1 (CcnD1) expressing cells were
also elevated 1.48-fold (p < 0.001) over wild type (11.7 ±
0.2%; n = 4) in approximately half of the 4DIV Zac1+m/-
explants (with phenotype: 17.3 ± 0.6%; n = 4/9; without
phenotype: 12.0 ± 0.7%; n = 5/9; Figure 3g–j). Cell prolif-
eration was thus specifically elevated at late stages of retin-
ogenesis in Zac1 mutants.
Ectopic division could occur if progenitors cycled more
extensively and/or committed precursors failed to exit the
cell cycle. Retinal progenitors are defined by cell cycle-
dependent, interkinetic nuclear movements, with G2/M-
phase, phospho-histoneH3 (pHH3)-expressing nuclei
lining the apical surface (Figure 3k,l), while S-phase
nuclei lie more basal in the onbl [32] (Additional data file
1 (e)). This contrasts to committed precursors that
migrate towards the vitreal (basal) surface of the inbl to
initiate formation of the mature retinal layers. We thus
used mitotic position to distinguish proliferating progen-
itors (apical mitoses) versus precursors (basal mitoses)
[33]. In Zac1+m/- retinae, the proportion of pHH3-labeled
nuclei was biased towards apical compartments in many
Zac1+m/- 4DIV explants (apical to basal ratio: wild type:
1.02 ± 0.07; n = 10; Zac1+m/-+phenotype: 2.30 ± 0.35; n =
3/8; Zac1+m/-: 1.19 ± 0.10; n = 5/8; Figure 3k–e), consist-
ent with an increase in progenitor and not precursor cell
divisions. Accordingly, most Pax6+ amacrine precursors
did not incorporate BrdU after a 30 minute exposure in
wild-type or Zac1+m/- 4DIV explants (Figure 4a,a',b,b';
Additional data file 5 (j)). Similarly, double labeling with
Math3, an amacrine and bipolar precursor marker,
revealed very few Math3/BrdU double+ cells in wild-type
and Zac1+m/- explants (Figure 4c,c',d,d'). Therefore, retinal
progenitor cells and not committed precursors are
dependent on Zac1 for cell cycle exit.
Apoptosis is reduced during late developmental stages in 
Zac1-deficient retinae
Compensatory mechanisms exist in the retina to ensure
that cellular content remains constant, with excess prolif-
eration often balanced by an increase in apoptosis
[34,35]. Given that Zac1 induces apoptosis when misex-
pressed in cell lines [24], we tested if it were also required
for the normal program of cell death in the retina, using
activated-caspase-3 (ac-3), a downstream effector and
early marker of commitment to the cell death pathway
[36]. During embryonic retinal development, apoptosis
peaks during the optic cup stage (E10–E11) in the pre-
sumptive retinal pigmented epithelium (rpe) and optic
stalk and again between E15.5–E17.5, primarily in retinal
cells adjacent to the optic nerve head [37-40]. We ana-
lyzed ac-3 staining in wild-type (n = 6) and Zac1 mutant
retinae (n = 6) at E10.5 and E15.5 but did not observe
more than a few apoptotic cells per retinal section in
either genotype (Additional data file 5 (a-d)). Similarly, at
E18.5 (p = 0.14; wild type: 0.4 ± 0.02%; n = 3; Zac1+m/-: 0.5
± 0.03%; n = 3) and in E18.5→2DIV explants (p = 0.93;
wild type: 3.5 ± 0.4%; n = 3; Zac1+m/-: 3.5 ± 0.2%; n = 3),
comparable levels of apoptosis were observed in both
genotypes (Figure 3q). In contrast, after 4 and 8DIV, there
were 3.48-fold (p < 0.01; wild type: 4.5 ± 1.0%; n = 7;
Zac1+m/-: 1.3 ± .0.2%; n = 5/6) and 2.02-fold (p < 0.05;
wild type: 2.9 ± 0.2%; n = 3; Zac1+m/-: 1.4 ± 0.3%; n = 4)
reductions, respectively, in the number of ac-3+ retinal
cells in Zac1+m/- explants (Figure 3o–r).
The reduction in cell death in Zac1+m/- explants could con-
tribute to the increase in amacrine and rod cell numbers.
However, the number of ac-3/Pax6-double+ amacrine
cells was similar in E18.5→4DIV explants from both gen-
otypes (p = 0.15; wild type: 1.6 ± 0.4%; n = 3; Zac1+m/-: 0.9
± 0.1%; n = 3; Additional data file 5 (e–i)). In contrast,
there was a 1.82-fold reduction in ac-3+ ONL photorecep-
tors in Zac1+m/- E18.5→8DIV explants (p < 0.05; wild type:
2.9 ± 0.2%; n = 3; Zac1+m/-: 1.60 ± 0.4%; n = 4). Zac1 defi-
ciency therefore perturbs pro-apoptotic pathways that
adjust cell numbers at late stages of retinogenesis, likely
contributing to the increase in rod cell number.
Zac1 is a direct negative regulator of proliferation and rod 
differentiation
To test if Zac1 was a direct negative regulator of amacrine
and rod cell fates, we established a gain-of-function assay,
electroporating retinal explants with a pCIG2 vector, con-
taining an internal ribosome entry site (IRES) 2-enhanced
green fluorescent protein (EGFP) cassette, or a pCIG2-
Zac1 vector, expressing both EGFP and Zac1 (Figure 5).
E15.5 and P0 retinal explants misexpressing Zac1 were
BrdU-pulse labeled 24 hours post-electroporation, reveal-
ing 1.96-fold and 2.49-fold reductions, respectively, in the
number of BrdU/EGFP-double+ cells compared to con-
trols at E15.5 (p < 0.05; pCIG2: 15.4 ± 1.6%; n = 3; Zac1:
7.9 ± 0.8%; n = 3; Figure 5g) and P0 (p < 0.05; pCIG2: 6.3
± 0.3%; n = 3; Zac1: 2.5 ± 1.0%; n = 3; Figure 5a–d,g). Zac1
therefore promotes cell cycle exit and/or increases cellPage 6 of 21
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Loss of Zac1 results in increased proliferation and reduced apoptosis at a late stage of retinogenesisFigure 3
Loss of Zac1 results in increased proliferation and reduced apoptosis at a late stage of retinogenesis. (a-d) BrdU labeling (red) 
of E18.5 wild-type and Zac1+m/- explants cultured 4DIV (a,b) or 6DIV (c,d). Arrowheads in (d) mark ectopic proliferating cells. 
(e) Percentage of BrdU+ nuclei in wild-type (black bar; E13.5: 2,824 BrdU+/8,235 DAPI+; E16.5: 2,234 BrdU+/10,663 DAPI+; 
E18.5: 2,859 BrdU+/27,380 DAPI+; E18.5→2DIV: 4,371 BrdU+/54,554 DAPI+; E18.5→4DIV: 988 BrdU+/55,300 DAPI+; 
E18.5→6DIV: 0 in 9 fields) and Zac1+m/- retinae (grey bars; E13.5: 3,555 BrdU+/10,413 DAPI+; E16.5: 3,369 BrdU+/15,707 
DAPI+; E18.5: 2,212 BrdU+/17,642 DAPI+; E18.5→2DIV: 3,298 BrdU+/35,085 DAPI+; E18.5→4DIV: 3,474 BrdU+/97,499 DAPI+; 
E18.5→6DIV: 54 BrdU+/11,618 DAPI+). (f) BrdU-labeling indices of individual wild-type (squares) and Zac1+m/- (triangles) 
E18.5→4DIV retinal explants. (g,h) E18.5→4DIV wild-type (g) and Zac1+m/- (h) retinal explants labeled with CcnD1 (red). (i) 
Percentage of Ccdn1+ cells in wild-type (black bar; 2,480 CcnD1+/21,329 DAPI+) and Zac1+m/- without aberrant proliferation 
(grey bar; 3,156 CcnD1+/26,328 DAPI+) and with a proliferative phenotype (w/φ; white bar; 3,266 CcnD1+/18,709 DAPI+) at 
4DIV. (j) Ccnd1-labeling indices of individual wild-type (squares) and Zac1+m/- (triangles) E18.5→4DIV retinal explants. (k,l) 
E18.5→4DIV wild-type (k) and Zac1+m/- (l) retinal explants labeled with pHH3 (red). (m) Apical (Ap) to basal (Ba) ratio of 
pHH3+ cells in wild-type (black bar; 808 ap:791 ba pHH3+) and Zac1+m/- without (grey bar; 971 ap:796 ba pHH3+) and with (w/
φ; white bar; 1,012 ap:480 ba pHH3+) a proliferative phenotype at 4DIV. (n) Ap:Ba ratios of pHH3+ cells in individual wild-type 
(squares) and Zac1+m/- (triangles) E18.5→4DIV retinal explants. (o-p) Active caspase-3 (Ac-3) expression (red) in wild-type 
and Zac1+m/- E18.5→4DIV explants. Blue is DAPI counterstain. (q) Percentage of apoptotic cells in the total population of wild-
type (black bars; E18.5: 71 ac-3+/18,341 DAPI+; E18.5→2DIV: 532 ac-3+/14,995 DAPI+; E18.5→4DIV: 1,266 ac-3+/27,321 
DAPI+; E18.5→8DIV: 294 ac-3+/10,209 DAPI+) and Zac1+m/- (white bars; E18.5: 67 ac-3+/13,768 DAPI+; E18.5→2DIV: 457 ac-
3+/13,195 DAPI+; E18.5→4DIV: 488 ac-3+/24,077 DAPI+; E18.5→8DIV: 212 ac-3+/14,377 DAPI+) retinae. (r) Distribution of 
individual wild-type (squares) and Zac1+m/- (triangles) ac-3-labeling indices at 4DIV.
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Amacrine cell genesis is elevated postnatally in Zac1+m/- retinaeFigure 4
Amacrine cell genesis is elevated postnatally in Zac1+m/- retinae. (a-d) E18.5→4DIV wild-type (a,a',c,c') and Zac1+m/- (b,b',d,d') 
explants co-labeled with BrdU (red, S-phase) and Pax6 (green; amacrine cells (a,a',b,b') or Math3 (green; amacrine and bipolar 
precursors in INL (c,c',d,d'). (e,f) E18.5→4DIV explants labeled with Pax6 alone (red). (g,g',h,h') Birthdating of E18.5→8DIV 
wild-type (g,g') and Zac1+m/- (h,h') retinal explants exposed to BrdU (green) at 2DIV and co-labeled with anti-Pax6 (red). BrdU/
Pax6 double+ cells are marked by arrowheads in (g',h'), which are high magnification images of boxed areas in (g,h), respectively. 
(i) Percentage of BrdU/Pax6 double+ nuclei (amacrine cells born at time of BrdU exposure) in wild-type (black bar; BrdU at 
1DIV: 562 BrdU/Pax6 double+/2,385 Pax6+; 2DIV: 527 BrdU/Pax6 double+/6,022 Pax6+; 4DIV: 77 BrdU/Pax6 double+/1,496 
Pax6+; all counts in 8DIV explants) and Zac1+m/- explants without an ECL (grey bar; BrdU at 1DIV: 1,307 BrdU/Pax6 double+/
4,084 Pax6+; 2DIV: 527 BrdU/Pax6 double+/4,926 Pax6+; 4DIV: 75 BrdU/Pax6 double+/1,660 Pax6+) and Zac1+m/-+ECL explants 
(white bar; BrdU at 1DIV: 2,126 BrdU/Pax6 double+/6,107 Pax6+; 2DIV: 883 BrdU/Pax6 double+/4,386 Pax6+; 4DIV: 335 BrdU/
Pax6 double+/3,587 Pax6+). (j) Model of amacrine cell genesis in wild-type (red line) versus Zac1+m/-+ECL (blue line) retinae.
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11cycle length in the murine retina. In contrast, Zac1 misex-
pression did not increase the number of ac-3+ cells com-
pared to controls 24 hour post-electroporation at P0 (p =
0.2; pCIG2: 3.1 ± 0.6%; n = 3; Zac1: 5.2 ± 1.3%; n = 3; Fig-
ure 5e,f,h), indicating that Zac1 is not sufficient to induce
retinal apoptosis.
To determine if Zac1 was a direct, negative regulator of rod
and/or amacrine fates, we examined the molecular phe-
notype of retinal cells electroporated at P0 and cultured
8DIV. No differences were observed in the ratio of GFP+
cells that became Pax6+ amacrine cells after electropora-
tion of pCIG2 (p = 0.73; 11.7 ± 3.4%; n = 6; Figure 5i–,k,s)
versus pCIG2-Zac1 (10.2 ± 2.3%; n = 6; Figure 5l,s). Sim-
ilarly, misexpression of Zac1 at E15.5 and E17.5, during
the peak of amacrine cell genesis, did not affect amacrine
cell number (Additional data file 6). In contrast, Zac1
misexpression at P0 resulted in a 4.49-fold reduction in
rhodopsin+ rods (p < 0.01; pCIG2: 52.3 ± 4.5%; n = 3;
Zac1: 11.6 ± 5.4%; n = 3; Figure 5m,n,s) and a 2.43-fold
reduction in Nr2e3-labeled rods (p < 0.05; pCIG2: 30.8 ±
3.6%; n = 3; Zac1: 12.7 ± 3.1%; n = 3; Figure 5s). Zac1-
misexpressing progenitors instead preferentially differen-
tiated into Chx10+ bipolar cells (1.72-fold increase; p <
0.05; pCIG2: 11.1 ± 1.8%; n = 6; Zac1: 19.1 ± 2.2%; n = 6)
and p27Kip1+ Müller glia (1.95-fold increase; p < 0.05;
pCIG2: 14.4 ± 2.2%; n = 6; Zac1: 28.1 ± 4.5%; n = 6), cells
types normally generated along with rods postnatally
(Figure 5o–s). Zac1 is thus a potent inhibitor of a rod fate
but does not directly suppress amacrine cell genesis.
Elevated amacrine cell genesis continues for a prolonged 
period in Zac1 mutants
To understand how Zac1 controls amacrine cell numbers,
we next determined when ectopic amacrine cells first
appeared in Zac1+m/- retinae. In mouse, amacrine cell gen-
esis normally peaks at E15.5, tapering off before birth [3]
(Figure 4j). At E18.5, genes involved in amacrine fate
specification/differentiation, including Math3, Foxn4,
NeuroD, Pax6 and Barhl2 [41-43], were expressed in an
indistinguishable manner in wild-type and Zac1+m/- reti-
nae, as were several other genes involved in the specifica-
tion of all other cell types (Additional data file 7). Cell fate
specification was thus grossly normal in E18.5 Zac1+m/-
retinae. In contrast, in E18.5→4DIV Zac1+m/- explants,
Pax6 (Figure 4a,a',b,b',e,f), Six3, Barhl2 and Math3 (Addi-
tional data file 8 (i–n)) expression increased, suggesting
the amacrine cell population expanded during early post-
natal stages in Zac1+m/- retinae.
To verify that amacrine genesis increased postnatally in
Zac1+m/- retinae, we performed birthdating. E18.5 retinal
explants were labeled with BrdU after 1, 2 and 4DIV and
then cultivated for 8DIV (Figure 4g,g',h,h'). More BrdU+/
Pax6+ amacrine cells were born at 1DIV (1.76-fold
increase; p < 0.05; wild type: 22.7 ± 3.4%; n = 3; Zac1+m/-
+ECL: 39.9 ± 3.8%; n = 4; Zac1+m/-: 29.8 ± 3.0%; n = 3),
2DIV (2.34-fold increase; p < 0.05; wild type: 8.6 ± 1.3%;
n = 7; Zac1+m/-+ECL: 20.0 ± 4.4%; n = 4; Zac1+m/-: 10.1 ±
2.8%; n = 6) and 4DIV (5.42-fold increase; p < 0.05; wild
type: 1.7 ± 1.0%; n = 6; Zac1+m/-+ECL: 9.2 ± 2.4%; n = 3;
Zac1+m/-: 4.3 ± 0.4%; n = 2; Figure 4g,g',h,h',i) in Zac1+m/-
+ECL explants compared to wild type, confirming that the
period of amacrine cell genesis was prolonged.
Negative feedback signals are deficient in Zac1+m/- 
amacrine cells
Our data suggested that the 'stop' or negative feedback sig-
nals that normally limit amacrine cell production later in
development [13,14] were deficient in Zac1+m/- retinae
(Figure 4j). To thus test if Zac1 was an essential compo-
nent of the amacrine cell negative feedback loop, we per-
formed aggregation assays. Dissociated E14.5 wild-type
retinal cells pre-labeled with BrdU were either cultured
alone as intact pellets or in pellet aggregations with a 20-
fold excess of dissociated E18.5 wild-type or Zac1+m/- reti-
nal cells, the latter populations serving as a source of ama-
crine cell feedback signals (Figure 6a). After 8DIV, pellets
were dissociated and Pax6+/BrdU+ amacrine cells derived
from E14.5 progenitors were quantified (Figure 6b–J). Of
the E14.5 cells cultured alone, 39.6 ± 3.4% (n = 9; 3 inde-
pendent experiments) of BrdU+cells became Pax6+ ama-
crine cells (Figure 6b–d,k). Consistent with feedback
signals being emitted from differentiating, E18.5 wild-
type cells, in co-cultures, amacrine cell development from
the E14.5-labeled cohort was reduced 1.40-fold (p < 0.01;
27.9 ± 2.0%; n = 10; Figure 6e–g,k). In contrast, amacrine
cell development from the E14.5 cohort was restored to
normal levels (compared to E14.5 cells alone) in mixed
aggregates containing E18.5 Zac1+m/- cells (p < 0.05, 37.7
± 2.4%; n = 21), indicative of impaired negative feedback
(Figure 6h–k). Zac1 is thus required in postnatal retinal
cells to negatively regulate amacrine cell genesis.
TGFβ signaling inhibits amacrine cell genesis in the retina
The cell non-autonomous requirement for Zac1 as a neg-
ative regulator of amacrine cell production implied that
this transcription factor must regulate the expression of an
unknown secreted signal. We focused on TGFβ cytokines,
given their role in feedback control in other systems. Spe-
cifically, we studied TGFβII, which regulates cell cycle exit
at late stages of rat retinogenesis [44], corresponding to
the period when Zac1+m/- cells proliferated aberrantly. In
E18.5 > 4DIV explants, the cognate receptors, TGFβRI and
TGFβRII, were expressed at low levels in dividing, Ccnd1+
progenitors (Figure 7a,b,d,e) and at higher levels in Pax6+
amacrine cells (Figure 7c,f). TGFβII was similarly
expressed in Pax6+ amacrine cells in the GCL and INL (Fig-
ure 7g–i) and at lower levels in Ccnd1+ progenitors in thePage 9 of 21
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Zac1 inhibits cell division and rod fate specificationFigure 5
Zac1 inhibits cell division and rod fate specification. (a-f) P0 retinae electroporated with pCIG2 control (a-c,e) or pCIG2-Zac1 
(d,f) cultured 1DIV. GFP+ electroporated cells (green (a-f)) labeled with anti-BrdU (red (c,d)) and anti-ac-3 (red (e,f)). Blue in 
(b) is DAPI counterstain. (g) Percentage of GFP+ cells that incorporated BrdU after electroporation of pCIG2 (black bar; 
E15.5→1DIV: 88 BrdU/GFP double+/542 GFP+; P0→1DIV: 124 BrdU/GFP double+/1,784 GFP+) and pCIG2-Zac1 (white bar; 
E15.5→1DIV: 24 BrdU/GFP double+/290 GFP+; P0→1DIV: 14 BrdU/GFP double+/816 GFP+). (h) Percentage of GFP+ cells that 
expressed ac-3 in P0→1DIV retinae electroporated with pCIG2 (black bar; 157 ac-3/GFP double+/5,402 GFP+) and pCIG2-
Zac1 (white bar; 97 ac-3/GFP double+/1,808 GFP+). (i-r) P0→8DIV retinae electroporated with pCIG2 (i-k,m,o,q) or pCIG2-
Zac1 (l,n,p,r). GFP+ electorporated cells (green (i-r)) co-labeled with Pax6 (red; amacrine cells (j-l)), rhodopsin (red; rods 
(m,n)), Chx10 (red; bipolar (o,p)) and p27Kip1 (red; Müller glia (q,r)). (s) Percentage of GFP+ cells expressing cell-type specific 
markers post-electroporation of pCIG2 (black bar; 290 Pax6/GFP double+/3,939 GFP+; 81 syntaxin/GFP double+/552 GFP+; 
955 rhodopsin/GFP double+/1,751 GFP+; 384 Nr2e3/GFP double+/1,261 GFP+; 279 Chx10/GFP double+/3,146 GFP+; 520 p27/
GFP double+/3,846 GFP+) or pCIG2-Zac1 (white bar; 140 Pax6/GFP double+/1,284 GFP+; 83 syntaxin/GFP double+/376 GFP+; 
56 rhodopsin/GFP double+/356 GFP+; 131 Nr2e3/GFP double+/816 GFP+; 263 Chx10/GFP double+/1,455 GFP+; 541 p27/GFP 
double+/1,888 GFP+). Arrowheads mark double+ cells. le, lens; Rho, Rhodopsin; Syn, Syntaxin.
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Zac1+m/- retinae lose amacrine cell feedback inhibitionFigure 6
Zac1+m/- retinae lose amacrine cell feedback inhibition. (a) Schematic of aggregation assay protocol. (b-j) Immunolabeling of 
dissociated cell pellets with Pax6 (red (c,d,f,g,i,j)), BrdU (green (b,d,e,g,h,j)) and merged image with DAPI (blue (d,g,j)). E14.5 
progenitors cultured alone (b-d) or with E18.5 wild-type (e-g) or Zac1+m/- (h-j) retinal cells. Arrowheads mark Pax6/BrdU dou-
ble+ nuclei (d,g,j). (k) Percentage of BrdU+ E14.5 cells that differentiated into Pax6+ amacrine cells when cultured alone (black 
bar; 1,085 BrdU/Pax6 double+/2,892 BrdU+) or with E18.5 wild-type (grey bar; 853 BrdU/Pax6 double+/3,215 BrdU+) or 
Zac1+m/- (white bar; 2,559 BrdU/Pax6 double+/7,196 BrdU+) retinal cells. n indicates number of individual retinal aggregates 
quantified.
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11onbl (not shown). Thus, TGFβII signaling could corre-
spond to the amacrine cell stop signal.
In Zac1 mutants, a notable reduction in TGFβII expression
was observed in onbl progenitors and in Pax6+ amacrine
cells in the INL, while GCL levels were similar to wild type
(Figure 7j–l). An overall reduction in TGFβII levels was
confirmed by western blot, demonstrating that the 25 kDa
isoform (note: labile 12 kDa mature form not detected)
was reduced in most (n = 8/12) Zac1+m/- explants (p <
0.05; signal normalized to β-actin; wild type: 1.5 ± 0.04; n
= 4; Zac1+m/-: 0.9 ± 0.2; n = 3/4; Figure 7o,p). To confirm
that TGFβ signaling was indeed reduced in Zac1+m/- reti-
nae, we examined expression of the downstream effector,
pSmad 2/3. In E18.5→4 DIV wild-type explants, pSmad2/
3 was expressed at diffuse levels throughout the retinae,
but at significantly higher levels in the GCL and the basal
half of the INL, where differentiated amacrine cells reside,
as well as at lower levels in dividing progenitor cells in the
onbl (Figure 7m). In contrast, pSmad2/3 levels were
decreased in the INL and onbl progenitors in Zac1+m/-
explants (Figure 7n). Accordingly, western blot analysis
revealed a significant reduction in pSmad2/3 protein lev-
els in Zac1+m/- versus wild-type E18.5 > 4 DIV explants
when normalized to β-actin (p < 0.01; n = 6/8 mutants
analyzed), while total Smad2/3 protein levels were similar
in both genotypes (n = 4 for each genotype; Figure 7o,q).
TGFβ signaling was thus attenuated in Zac1+m/-retinae.
To determine if reduced TGFβ signaling results in ama-
crine cell expansion, conditional TGFβRII mutants were
analyzed. Mice heterozygous (Figure 8a,c,e,g) or
homozygous (Figure 8b,d,f,h,i,j) for a floxed mutant
allele of TGFβRII (hereafter referred to as flTGFβRII; [45])
were crossed with mice carrying a R26R reporter and a
GLAST::CreERT2 knock-in allele [46]. GLAST was
expressed in the embryonic retina (Figure 8a, inset) and,
accordingly, tamoxifen administered at E16 specifically
induced CreERT2 recombinase activity in the E18.5 retina
as evidenced by R26R reporter expression (that is, X-Gal
staining in tamoxifen injected (Figure 8b) and not un-
injected control (Figure 8a) retinae). Accordingly, expres-
sion of TGFβRII was reduced in E18.5 flTGFβRII-/- (Figure
8d) compared to flTGFβRII+/- retinae (Figure 8c). An overt
expansion of the amacrine cell layer, as labeled by Pax6
(Figure 8e,f) and syntaxin (Figure 8g–j), was also evident
in tamoxifen-induced E18.5 flTGFβRII-/- mutant retinae
(Figure 8f,h and Figure 8i,j show different mutants) com-
pared to wild-type controls (Figure 8e,g).
While the analysis of TGFβRII mutants supported a role
for this signaling pathway in regulating amacrine cell
number, we were precluded from analyzing the effects of
mutating TGFβRII at postnatal stages as the mutants unex-
pectedly died at early postnatal stages. We therefore used
a complementary pharmacological approach to mimic
the late reduction in TGFβ signaling observed in Zac1
mutant retinae. The pharmacological inhibition of TGFβII
in the early postnatal rat retina increases proliferation and
cell number [44], but specific effects on amacrine cell gen-
esis were not analyzed. In accordance with experiments in
rat [44], addition of 0.5 μg/ml soluble TGFβRII-Fc recep-
tor to E18.5→8DIV retinal explants resulted in a 1.55-fold
increase in INL/GCL cell number compared to vehicle
controls (p < 0.01; control: 387.1 ± 35.0 cells/field; n = 3;
TGFβRII-Fc: 601.6 ± 62.1 cells/field; n = 3; Figure 8k,l),
while 0.1 μg/ml had no effect (not shown). Moreover, the
inhibition of TGFβII signaling resulted in a 1.50-fold
increase in the absolute number of amacrine cells (p <
0.01; vehicle control: 220.2 ± 5.9 cells/field; n = 3; TGF-
βRII-Fc: 331.2 ± 15.3 cells/field; n = 3; Figure 8k–m).
These results are consistent with a requirement for TGFβ
signaling to negatively regulate amacrine cell number dur-
ing development.
Next, to show that attenuation of TGFβ signaling under-
lies amacrine cell expansion in Zac1+m/- retinae, we per-
formed a rescue experiment. Recombinant TGFβII (or
vehicle control) was added to wild-type and Zac1+m/-
E18.5→8DIV explants. In control explants, the percentage
of Pax6+ amacrine cells was elevated 1.38-fold in Zac1+m/-
+ECL versus wild-type explants (p < 0.01; wild type: 53.6
± 4.2% INL/GCL cells; n = 4; Zac1+m/-+ECL; 68.7 ± 4.8%
INL/ECL/GCL cells; n = 3; Figure 8p). In contrast, follow-
ing exposure to TGFβII for 8DIV, the percentage of ama-
crine cells was equivalent in wild-type and Zac1+m/-+ECL
explants (wild type: 60.4 ± 2.5% INL/GCL cells; n = 3;
Zac1+m/-+ECL: 61.5 ± 2.9% INL/ECL/GCL cells; n = 3; Fig-
ure 8n–p). Strikingly, however, an ECL still formed in
TGFβII-treated Zac1+m/- explants (Figure 8o), suggesting
that an alternative, non-TGFβ-mediated pathway under-
lies amacrine cell migration defects. This is also consistent
with the inability of TGFβRII-Fc to induce an ECL (Figure
8l). These studies implicate attenuated TGFβII signaling in
amacrine cell expansion in Zac1+m/- retinae.
Discussion
The development of a functional retina requires that
appropriate numbers of each cell type be generated.
Hence, the molecular events that guide cell fate specifica-
tion and differentiation must be tightly coordinated with
those that govern cell number control. Here we demon-
strate that the Zac1 tumor suppressor is an essential nega-
tive regulator of retinal size, controlling the absolute
number of rod photoreceptors and amacrine cells gener-
ated during development. Strikingly, Zac1 regulates rod
and amacrine cell genesis through distinct cell autono-
mous and non autonomous mechanisms, respectively
(Figure 9). While Zac1 is a direct negative regulator of a
rod photoreceptor fate, it regulates amacrine cell genesisPage 12 of 21
(page number not for citation purposes)
Neural Development 2007, 2:11 http://www.neuraldevelopment.com/content/2/1/11
Page 13 of 21
(page number not for citation purposes)
Zac1 regulates TGFβII signaling in the retinaFigure 7
Zac1 regulates TGFβII signaling in the retina. (a-f) Co-expression of TGFβRI (green (a-c)) and TGFβRII (green (d-f)) with 
Ccnd1 (red, proliferating progenitors (b,e)) and Pax6 (red, amacrine cells (c,f)) in E18.5 > 4DIV wild-type retinal explants. (g-l) 
TGFβII expression in E18.5→4DIV wild-type (green (g-i)) and Zac1+m/- (green (j-l)) retinal explants co-labeled with Pax6 (red, 
amacrine cells (i,l)). Arrowheads mark double+ cells. Asterisk in (j) marks reduction in onbl/INL expression. (m,n) Expression 
of pSmad2/3 in E18.5→4DIV wild-type (m) and Zac1+m/- (n) retinal explants. (o) Western blot analysis of TGFβII, pSmad2/3, 
total Smad2/3, and β-actin. Asterisks in (o) indicate mutants with reduced expression of TGFβII or pSmad2/3. (p,q) Quantita-
tion of expression levels normalized to β-actin via densitometry for TGFβII (p) and pSmad2/3 (q).
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TGFβII negatively regulates amacrine cell genesisFigure 8
TGFβII negatively regulates amacrine cell genesis. (a,b) X-gal staining of E18.5 GLAST::CreERT2+/-;R26R reporter+ transgenic 
without (a) and with (b) administration of tamoxifen at E16. Inset in (a) shows GLAST immunostaining of E15.5 retina. (c-j) 
Analysis of TGFβRII+/-;GLAST::CreERT2+/-;R26R+ (c,e,g) and TGFβRII-/-;GLAST::CreERT2+/-;R26R+ (d,f,h,i,j) retinae immunos-
tained with anti-TGFβRII (c,d), Pax6 (e,f) and syntaxin (g-j). Arrowheads in (i) mark ectopic amacrine cell clusters. TGFβRII-/- 
retinae in panels (d-h) and (i,j) are from two different mutant embryos. (k,l) E18.5 > 8DIV retinal explants cultured with vehi-
cle control (k) or TGFβRII-Fc (l) and labeled with anti-Pax6. (m) Percentage of Pax6+ amacrine cells/field in vehicle control 
(black bar; 2,148 Pax6+ in 10 fields) and TGFβRII-Fc treated (white bar; 4,966 Pax6+ in 15 fields) retinal explants. (n,o) 
E18.5→8DIV wild-type (n) or Zac1+m/- (o) retinal explants cultured with rTGFβII. Asterisk in (o) indicates ECL formation in 
Zac1+m/- retinae even in the presence of rTGFβII. (p) Percentage of amacrine cells in wild-type explants (black bar; vehicle con-
trol: 1,761 Pax6+/3,353 DAPI+; rTGFβII: 2,605 Pax6+/4,301 DAPI+ in INL+GCL) and Zac1+m/-+ECL explants (white bar; vehicle 
control: 2,232 Pax6+/3,328 DAPI+; rTGFβII: 3,243 Pax6+/5,282 DAPI+ in INL+GCL).
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an amacrine cell negative feedback signal. Zac1 and TGF-
βII thus join a growing list of tumor suppressor genes with
established roles in retinogenesis (for example, Rb, p53,
p27Kip1 [33,35,40,44,47-52]), but are the first tumor sur-
veillance molecules shown to control neuronal number
through a negative feedback or 'cell sensing' mechanism.
Zac1 promotes cell cycle exit and apoptosis in the 
developing retina
The widespread expression of Zac1 in dividing progenitor
cells in the retina (this study) and throughout the devel-
oping neural tube [25,53-55] suggested that it would have
an early role in neural development. Unexpectedly, we
found that in the murine retina, Zac1 function is restricted
to the early postnatal period. While we cannot rule out the
possibility that Zac1 functions redundantly with other fac-
tors to regulate early events in retinal development, we
would predict that the tumor suppressor-like properties of
Zac1 would have to be actively suppressed during early
retinal development as most cells that express Zac1 at
these stages continue to divide for some time. Indeed, we
show here that Zac1 is required to promote cell cycle exit
only at late stages of retinogenesis, a context dependency
that is also characteristic of other tumor suppressor genes
and oncogenes [56]. Specifically, we show that, in Zac1
mutants, retinal progenitor cells divide excessively, simi-
lar to p27Kip1 mutants [35,52] and in contrast to Rb
mutants, where committed precursors instead fail to exit
the cell cycle [33,47,48]. Our demonstration that cyclin
D1 expression is upregulated in Zac1+m/- retinae provides
some insight into the molecular mechanisms underlying
Zac1-mediated control of the cell cycle. However, several
observations make it unlikely that Zac1 functions directly
through p27Kip1 or the related cyclin dependent kinase
(CDK) inhibitor (CDKI) p57Kip2 to regulate cell cycle exit.
Firstly, p27Kip1 is not required in a temporally restricted
manner in the retina, and p57Kip2 is only required at early
stages of retinal development [35,52,57], which contrasts
with the late temporal requirement for Zac1. Furthermore,
expression of the Kip family CDKIs was not altered in
Zac1 mutants, and while there was an increase in p27Kip1
expression following Zac1 misexpression, it was specific
to Müller glia, where this CDKI is normally expressed, and
not observed in other cell types. Moreover, a previous cell
culture study reported that Zac1 promoted cell cycle exit
independently of Kip-family CDKIs or other classic cell
cycle regulators such as Rb [24].
Zac1 functions as a direct negative regulator of rod cell 
fate
The requirement for Zac1 to promote cell cycle exit and
apoptosis at late stages of retinal development likely con-
tributes to the formation of hypercellular retinae in
mutants, but does not explain why rod photoreceptors
and amacrine cells are the only two cell types that are spe-
cifically expanded. Strikingly, misexpression of Zac1
robustly inhibited rod differentiation, implicating Zac1 as
a bona fide negative regulator of this cell fate. Accordingly,
Zac1 expression declines in progenitor cells at P0 when
rod photoreceptor genesis begins to peak. Zac1 is also not
expressed in differentiated ONL photoreceptors. How-
ever, we cannot rule out the possibility that cell non-
autonomous mechanisms may also underlie the expan-
sion of the rod pool in Zac1+m/- retinae. Indeed, we found
that the generation of excess rods is directly linked to the
formation of an ECL, both occuring in the same approxi-
mately 55% of Zac1+m/- retinae. Notably, we implicated
attenuated TGFβ signaling [58], a proapoptotic pathway,
in the amacrine cell expansion. However, reduced TGFβ
signaling may also underlie the decreased apoptosis we
observed in Zac1+m/- ONLs, consequently contributing to
the expansion of the rod pool.
Zac1 misexpression also increased bipolar and Müller
glial production in our gain-of-function assays, but rather
than proposing that Zac1 is instructive for these fates, we
favor the interpretation that progenitor cells prevented
from adopting a rod fate instead acquire later-born fates
by default. Accordingly, in Zac1+m/- retinae, we did not
observe compensatory decreases in bipolar and Müller
glial cell number. Nevertheless, in Xenopus, murine Zac1
also promoted Müller glial as well as RGC genesis, sug-
gesting it might be instructive for a glial identity in differ-
ent vertebrate species [26]. However, there are numerous
examples whereby misexpression of a murine gene in
Xenopus specifies distinct cell fates compared to misex-
pression in a mouse model (for example, Mash1 promotes
a rod fate when misexpressed in mouse and a bipolar fate
in Xenopus [59,60]. Moreover, in a previous study we
showed that murine Zac1 unexpectedly promoted prolif-
eration in Xenopus retina [26], in sharp contrast to its abil-
ity to promote cell cycle exit in the murine retina (this
study) and cell lines in vitro [21,24]. To simplify our
model of Zac1 retinal function, we therefore consider
results obtained in mouse and Xenopus as independent
systems where gene function may differ substantively.
Zac1 regulates amacrine cell production cell non-
autonomously
Previous studies based on ablation of mature amacrine
cells [14] and aggregation of early progenitors with post-
mitotic retinal cells [13] demonstrated that amacrine cell
number is regulated by negative feedback, but the molec-
ular mechanisms were unknown. Using similar aggrega-
tion assays, we showed that Zac1 is required in postnatal
retinal cells to limit the number of amacrine cells gener-
ated [14]. With the exception of rods, numbers of all other
retinal cells were not grossly perturbed in Zac1 mutants.
The loss of amacrine cell negative feedback therefore doesPage 15 of 21
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cell aggregation experiments [1,13]. We thus propose a
model whereby initial reductions in amacrine cell genesis,
beginning at E16 in wild-type retinae, occurs when pro-
genitors switch to the next competence window to make
later-born rods, bipolar cells and Müller glia, an event that
is Zac1-independent. This would be followed early post-
natally by Zac1/TGFβII-regulated feedback inhibition
serving as the final signal to halt amacrine cell genesis
(Figure 9).
Feedback pathways exist in diverse biological systems,
including the counting factor in Dictyostelium, which dic-
tates group size [2], Drosophila miRNA9a, which regulates
sensory organ precursor number by downregulating
Senseless expression [61], and the well established role of
feedback signals in regulating cell number in vertebrate
liver, pancreas, olfactory epithelium and retina [2]. Feed-
back pathways operate by secreting limiting amounts of
extrinsic signals that must reach threshold levels to signal
cessation of cell genesis [2]. Our data support the idea
Zac1 acts in post-mitotic amacrine cells during the postna-
tal period to regulate TGFβII expression, which in turn
suppresses amacrine cell genesis. However, our analysis of
TGFβRII mutants also indicates that deleting TGFβ signal-
ing earlier in development (that is, from E16 to E18.5),
during the peak period of amacrine cell genesis, can also
influence amacrine cell genesis. Invoking a threshold
model for TGFβII could help explain why defects in cell
cycle exit and expansion of the amacrine cell population
were not completely penetrant phenotypes in Zac1
mutants. Indeed, developmental processes are known to
be highly sensitive to levels of signaling molecules, and
stochastic differences in signaling often account for phe-
notypic variability [62]. Moreover, abrogation of the feed-
back pathway regulating sense organ production in
Drosophila, through deletion of miR-9a, similarly results in
variable expressivity and penetrance of neuronal overpro-
duction [61].
Notably, amacrine cell migration defects and the subse-
quent formation of an ECL were independent of attenu-
ated TGFβ signaling in Zac1 mutant retinae. While we
attribute the generation of an ECL to the mutation of
Zac1, it remains a possibility that ECL formation requires
both this genetic deletion as well as the loss of RGCs that
occurs in retinal explant cultures, a possibility we cannot
directly address given that Zac1 mutants die at birth.
Another possibility is that Zac1 directly regulates cell
migration by controlling the expression of cell adhesion
genes, an idea based on a meta-analysis of microarray data
in which several extracellular matrix molecules that could
potentially modulate cell adhesion/migration were found
to be co-regulated with Zac1 [23]. The underlying cause of
ECL formation is the subject of current investigations.
Conclusion
Here we demonstrate that Zac1 is an essential negative
regulator of retinal size, controlling the absolute number
of rod and amacrine cells generated during development.
Strikingly, while Zac1 acts as a direct negative regulator of
a rod fate, it negatively regulates amacrine cell genesis via
TGFβII-mediated negative feedback inhibition. Zac1 and
TGFβII are thus the first tumor surveillance molecules
shown to control neuronal number through a negative
feedback, 'cell sensing' mechanism. In summary, Zac1 reg-
ulates cell number and migration in the developing retina,
highly reminiscent of its function in the prevention of
tumor formation, suggesting that similar cellular and
molecular mechanisms may underlie these processes.
Materials and methods
Animals and genotyping
For embryo staging, the day of the vaginal plug was con-
sidered E0.5. Generation of the Zac1 mutant allele was
previously described [23]. The Zac1 mutant allele was
maintained on a C57BL/6 background. Zac1+m/- hetero-
zygous embryos were generated by crossing Zac1+/- heter-
ozygous males to C57BL/6 females. Primers for PCR
genotyping (35 cycles; 94° for 1 minute, 60° for 1
minute, and 72° for 1 minute) of Zac1 were: wild type 5':
AGTGACTCCCCACCTTCTTTCTG; wild type 3': CTT-
GCCACATTTTTGACAGCG; mutant 5': TGACCGCTTC-
CTCGTGCTTTAC; mutant 3':
CCCCCCAGAATAGAATGACACC. Genotyping of
GLAST::CreERT2 and R26R reporter mice were previously
described [46]. The floxed TGFβRII allele was previously
reported [45] and was genotyped by PCR (38 cycles; 95°
for 30 s, 62° for 30 s, and 72° for 40 s) with: primer 1 5':
TGG GGATAGAGGTAGAAAGACATA-3'; primer 2 5': TAT-
GGACTGGCT TTTGTATTC. To induce deletion of the
TGFβRII gene, 3 mg of tamoxifen was administered by
oral gavage at E16.0 as previously described [46].
RNA in situ hybridization
For RNA in situ hybridization, tissue preparation and
experimental procedures were followed as previously
described [25]. Briefly, tissue was fixed in 4% paraformal-
dehyde (PFA)/1X-phosphate buffered saline (PBS) over-
night at 4°C, cryopreserved in 20%sucrose/1X PBS
overnight at 4°C and embedded in Cryomatrix™ (Ana-
tomical Pathology USA [Pittsburgh, PA, USA]). Digoxy-
genin (dig)-labelled probes were generated using a dig-
UTP labeling mix and T3, T7 or SP6 RNA polymerases
according to the manufacturer's instructions (Roche
[Laval, QC, Canada]). Mouse probes included Zac1 [25],
Hes1, Hes5, Mash1 [63], Ngn2 [64], Math3 [65], Math5
[60], NeuroD [66], Pax6 [67], Rx [68], Crx [69], Chx10
[70]. Foxn4 [42] and Barhl2 [71], Six3 [41] and s-opsin
[72].Page 16 of 21
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For immunohistochemistry, fixation in 4% PFA/1 × PBS
was shortened to 1–2 h at 4°C. Primary antibodies were
incubated on slides overnight at 4°C or 1 h at room tem-
perature. The following primary antibodies were used:
rabbit active-caspase 3 (1/500; Promega [Madison, WI,
USA]), mouse Brn3a (1/500; Chemicon [Temecula, CA,
USA]), goat anti-Brn3b (1/250; Santa Cruz [Santa Cruz,
CA, USA]), mouse anti-BrdU (5-bromo-2'-deoxyuridine,
1/500; Roche), rat-anti-BrdU (1/10; Oxford Biotech [now
Antibodies by Design, Raleigh, NC, USA]), rabbit anti-cal-
bindin (1/1,000; SWANT [Bellinzona, Switzerland]),
mouse anti-cyclinD1 (1/100; Santa Cruz), rabbit anti-
Chx10 (1/50; Rod McInnes), mouse anti-CRALBP (1/
5,000; Jack Saari), rabbit anti-GFP (1/500, Chemicon),
goat anti-Math3 (1/100, Santa Cruz), mouse anti-neuro-
filament 200 (1/500; NF200, Sigma [Oakville, ON, Can-
ada]), rabbit anti-Nr2e3 (1/100; Chemicon), rabbit anti-
Pax6 (1/500; Babco [Richmond, CA, USA]]), mouse anti-
Pax6 (1/4, Developmental Studies Hybridoma Bank
[Iowa City, IA, USA]), rabbit anti-p27Kip1 (1/500; Neo-
Marker Lab Vision, [Freemont, CA, USA] ]), mouse anti-
protein kinase C (PKC; 1/500; Sigma), mouse anti-rho-
dopsin (1/500; Chemicon), mouse anti-syntaxin (1/
2,000; Sigma), rabbit anti-TGFβII (1/100; Santa Cruz),
rabbit anti-TGFβRI (1/100; Santa Cruz), rabbit anti-TGF-
βRII (1/100; Santa Cruz), rabbit anti-phospho-Smad2/3
(1/100; Santa Cruz), guinea pig anti-GLAST (1/8,000;
Chemicon) and rabbit anti-Zac1 (1/1,000 [24]). Primary
antibodies were washed 3 times in PBS with 0.1% triton
X-100 (PBT) and detected using secondary antibodies
conjugated with Cy3- (1/500; Jackson ImmunoResearch
Laboratories, Inc. [West Grove, PA, USA]) or Alexa488 (1/
500; Molecular Probes [Invitrogen, Eugene, OR, USA]).
Secondary antibodies were diluted in PBT and left on the
slides for 1 h prior to 3–10 minute washes with PBT. Note
that the TSA™ Tyramide-Fluorescein Immunostaining Kit
(NEL701, Perkin-Elmer [Shelton, CT, USA]) was used to
amplify anti-TGFβII, TGFβRI, TGFβRII and phospho-
Smad2/3 immunostaining as per the manufacturer's
instructions. Peanut Agglutinin (PNA) staining was car-
ried out using a 1:200 dilution of the PNA lectin incu-
bated at 37°C for 30 minutes. Sections were then stained
for five minutes with DAPI, washed an additional three
times with PBS, and mounted with AquaPolymount. β-
Galactosidase activity was detected using X-gal as a sub-
strate as previously described [73].
BrdU labeling
To label S-phase progenitors, pregnant females were
injected intraperitoneally with 100 μg/g body weight
BrdU (Sigma) 30 minutes prior to sacrifice. For birthdat-
ing studies, BrdU was added to the culture media at a final
concentration of 10 μM. Embryos were processed for anti-
BrdU staining as above except for the addition of a pre-
treatment with 2N HCl for 30 minutes at 37°C. BrdU
immunolabeling after RNA in situ hybridization was car-
ried out using 3,3'-diaminobenzidine (DAB) as a sub-
strate using the Vectastain kit (Vector Laboratories Inc.
[Burlingame, CA, USA]).
Western blotting
Retinae were lysed for 15 minutes on ice in RIPA buffer
(1% SDS, 1% sodium deoxycholate, 0.1% Nonidet P-40
in 50 mM Tris-HCl (pH 7.6)/150 mM NaCl) plus protease
(Complete inhibitor tablet, Roche) and phosphatase (5
mM NaF and 1 mM orthovanadate) inhibitors. Cell
lysates were cleared and protein concentrations deter-
mined via Bradford analysis. Cell free extract (25 μg) was
loaded per lane on a 12% (Smad/phospho-Smad) or 15%
(TGFβII) SDS-PAGE gel. Protein was then transferred to
PVDF membrane at 80 V for 1 h. Membranes were
blocked in 5% skim milk powder or 5% bovine serum
albumin (for phospho-Smad) in tris-buffered saline with
0.1% tween 20 (TBST) and then incubated with anti-
phospho-Smad2/3 (1/200; Santa Cruz), Smad2/3 (1/200;
Santa Cruz), TGFβII (1/200; Santa Cruz) or anti-β-actin
(1/5,000, AbCam [Cambridge, MA, USA]) overnight at
4°C. Membranes were washed three times for ten minutes
Model of Zac1 function in the retinaFigure 9
Model of Zac1 function in the retina. Zac1 negatively regu-
lates amacrine cell number cell non-autonomously, control-
ling TGFβII expression, which inhibits amacrine cell genesis at 
threshold levels (negative feedback). In contrast, Zac1 nega-
tively regulates rod number cell-autonomously. Zac1 nega-
tively regulates (either directly or indirectly) the expression 
of genes involved in the specification/differentiation of an 
amacrine cell (Pax6, Six3, Foxn4, Math3, NeuroD, Bhlhb5, 
Barhl2) and rod cell (Rb, Otx2, Crx, Nr2e3, Nrl) fate by con-
trolling the decision by retinal progenitor cells to differenti-
ate along these lineages. AC, amacrine cell; APC, amacrine 
precursor cell; PPC, photoreceptor precursor cell; RPC, ret-
inal progenitor cell.Page 17 of 21
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(HRP)-conjugated secondary antibodies and develop-
ment with ECL (Roche).
Retinal explants
Retinae were dissected and grown as explants as previ-
ously described [74]. Briefly, the retinal pigmented epithe-
lium (RPE) and lens were removed from dissected eyes,
and the retina was flattened and cultured GCL-up on a
Nucleopore Track-Etch membrane (13 mm; Whatman
[Maldstone, England]) in explant media (50% MEM, 25%
Hanks Solution, 25% horse serum, 6.75 mg/ml glucose,
200 μM L-glutamine, 2.5 mM HEPES) at 37°C in 5% CO2.
The TGFβRII-Fc soluble receptor inhibitor (R&D systems
[Burlington, ON, Canada]) was added at 0.5 μg/ml dis-
solved in PBS (vehicle control) every second day as
described [44]. Recombinant TGFβII (R&D systems) was
added to explants every second day at 1 ng/ml.
Aggregation assays
Retinae were dissected, dissociated into single cell suspen-
sions and cultured as aggregates essentially as described
[13,75]. Briefly, E14.5 wild-type retinae were dissociated
in trypsin (10 min/37°C) and triturated in DMEM/10%
fetal calf serum with 100 μl DNAseI (2 mg/ml). Dissoci-
ated progenitors were labeled in media with 10 μM BrdU
for 1 h. BrdU was washed out and cells were resuspended
in culture media at 5 × 105 cells/ml. For co-cultures, 100
μl (5 × 104 cells) of labeled E14.5 progenitors were added
to a 20-fold excess (1 × 106 cells) of dissociated E18.5
wild-type or Zac1 mutant cells. Aggregated cells were pel-
leted by centrifuging for 8 minutes at 2,200 rpm and pel-
lets were transferred after 1 h onto Nucleopore
membranes and cultured 8DIV. Pellets were then dissoci-
ated and plated on poly-D-lysine-coated slides for immu-
nostaining.
Retinal electroporation
For misexpression, full-length Zac1 cDNA [26] was cloned
into a pCIG2 expression vector containing a CMV-
enhancer/chicken β-actin promoter and IRES-EGFP cas-
sette (gift from Franck Polleux) [76]. For electroporation,
eyes were dissected and the RPE removed prior to immer-
sion in 10 μl DNA (3 μg/μl) on a 3% agarose gel plug.
Platinum electrodes were placed on either side of the eye
(E15.5, 4 mm spacing; and E18.5, 5 mm spacing) and
seven 20 ms pulses of 25 V were applied. Electroporated
retinae were then cultured as explants.
Cell counts and statistical analysis
Immunoreactive cells were counted in sections adjacent to
the optic nerve or site of optic nerve transection in
explants. In all experiments, cells were counted from a
minimum of three embryos (or explants) and three sec-
tions per embryo (or explant). The total number of indi-
vidual retinae analyzed per experiment (n values) is
presented in the results section and the total number of
cells counted per experiment is presented in the figure leg-
ends. All quantification was done from photomicro-
graphs representing a 0.33 mm × 0.25 mm counting field.
Statistical variation was determined using the standard
error of the mean (SEM). Statistical significance was calcu-
lated using a Student's t-test, individually comparing
experimental bars against wild-type or control counts.
Additional data files
The following additional data are available with the
online version of this paper. Additional data file 1 is a fig-
ure showing that Zac1 is expressed in dividing progenitors
at embryonic stages and differentiated cells at postnatal
stages. Additional data file 2 is a figure showing Zac1 gen-
otyping and verification of maternal imprinting in the
embryonic retina. Additional data file 3 is a figure show-
ing that equivalent numbers of bipolar cells, Müller glia,
horizontal cells and cone photoreceptors develop in wild-
type and Zac1 mutant retinal explants, while the number
of amacrine cells increased in Zac1 mutant retinae. Addi-
tional data file 4 is a figure showing that RGC differentia-
tion is unperturbed in Zac1-deficient retinae at E18.5.
Additional data file 5 is a figure showing that amacrine
cell precursors do not undergo more apoptosis or divide
ectopically in Zac1 mutant retinae. Additional data file 6
is a figure showing that misexpression of Zac1 in the ret-
ina does not affect amacrine cells genesis. Additional data
file 7 is a figure showing that the molecular profile of
Zac1-deficient retinal progenitors is unperturbed at E18.5.
Additional data file 8 is a figure showing that amacrine
cell marker expression domains are expanded in E18.5
Zac1 mutant retinal explants cultured 4 DIV.
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Additional data File 1
Zac1 is expressed in dividing progenitors at embryonic stages and differ-
entiated cells at postnatal stages. (a-c) E15.5 retinae co-immunolabeled 
with anti-Zac1 (red, a,c) and anti-syntaxin (green, b) and merged image 
(c). (d-f) E15.5 retinae co-immunolabeled with anti-Zac1 (red, d) and 
anti-BrdU (green, e) and merged image (f). (g,h) Expression of Zac1 
transcripts (g) and protein (h) in P21 retinae.




Zac1 genotyping and verification of maternal imprinting in the embryonic 
retina. (a) PCR genotyping of wild-type and Zac1 mutant alleles. (b,c) 
Zac1 immunostaining of E15.5 wild-type and Zac1+m/- mutant retinae 
revealed a loss of expression in heterozygous embryos carrying a maternal 
wild-type allele.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S2.jpeg]
Additional data File 3
Equivalent numbers of bipolar cells, Müller glia, horizontal cells and cone 
photoreceptors develop in wild-type and Zac1 mutant retinal explants, 
while the number of amacrine cells increased in Zac1 mutant retinae. 
E18.5 wild-type (a,c,e,g,i,k,m,o,q) and Zac1-deficient 
(b,d,f,h,j,l,n,p,r) retinae were cultured 8DIV and labelled with Chx10 
(red, a,b) for bipolar cells, p27Kip1 (red, c,d) and CRALBP (red, e,f) for 
Müller glia, peanut agglutinin (PNA, green, g,h) and s-opsin (i,j) for 
cones, Bhlhb5 (green, k,l) for GABAergic amacrine cells, calbindin for 
horizontal cell bodies (red, with processes in outer plexiform layer; m,n) 
and AII amacrine cells (deeper in INL; m,n), and GABA (red, o,p) and 
GlyT1 (red, q,r) for amacrine cell subtypes. Explants were counterstained 
with DAPI (blue).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S3.jpeg]
Additional data File 4
RGC differentiation is unperturbed in Zac1-deficient retinae at E18.5. 
Brn3a (a,b) and Brn3b (c,d) immunolabeling of RGCs in wild-type (a,c) 
and Zac1 mutant (b,d) retinae at E18.5. Quantitation of Brn3a (e) and 
Brn3b (f) expressing cells revealed equivalent numbers of RGCs in wild-
type (n = 3 retinae; black bar) and Zac1 mutant (n = 3 retinae; white 
bar) retinae. Brn3a (p = 0.95; wild-type: 6.4 ± 1.0% retinal cells; 774 
Brn3a+/12138 DAPI+; Zac1 mutant: 7.4 ± 0.4%; 743 Brn3a+/10123 
DAPI+) and Brn3b (p = 0.23; wild-type: 3.3 ± 0.7%; 269 Brn3b+/6813 
DAPI+; Zac1 mutant: 5.0 ± 0.7%; 393 Brn3b+/7818 DAPI+).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S4.jpeg]
Additional data File 5
Amacrine cell precursors do not undergo more apoptosis or divide ectopi-
cally in Zac1 mutant retinae. (a-d) E10.5 (a,b) and E15.5 (c,d) retinae 
immunostained for activated caspase-3 (ac-3) (red) in wild-type (a,c) 
and Zac1+m/-(b,d) embryos. Inserts in c,d are high magnification images 
of ac-3+ cells. (e-h) Ac-3 (red)/Pax6 (green) double+ cells label apoptotic 
amacrine cells in E18.5→4DIV explants. g and h are high magnification 
images of boxed areas in e and f, respectively. Ac-3+ amacrine cells are 
marked by arrowheads (g,h). (i) Percentage of Pax6+/ac-3+ apoptotic 
amacrine cells in wild-type (black bars; 45 ac-3/Pax6 double+/2925 
Pax6+) and Zac1+m/- (white bars; 22 ac-3/Pax6 double+/2538 Pax6+) 
E18.5→4DIV explants. (j) Percentage of BrdU+/Pax6+ dividing ama-
crine cells in total Pax6+ population in E18.5 explants cultured 1DIV, 
2DIV and 4DIV. 1DIV (p = 0.40; wild-type: 1.1 ± 0.3%; n = 3 explants; 
12 BrdU/Pax6 double+/1071 Pax6+; Zac1 mutant: 0.7 ± 0.2%; n = 3 
explants; 10 BrdU/Pax6 double+/1386 Pax6+), 2DIV (p = 0.76; wild-
type: 0.9 ± 0.3%; n = 3 explants; 16 BrdU/Pax6 double+/1698 Pax6+; 
Zac1 mutant: 0.8 ± 0.3%; n = 3 explants; 16 BrdU/Pax6 double+/1983 
Pax6+) and 4DIV (p = 0.44; wild-type: 0.2 ± 0.2%; n = 3 explants; 5 
BrdU/Pax6 double+/712 Pax6+; Zac1 mutant: 0.4 ± 0.3%; n = 3 
explants; 16 BrdU/Pax6 double+/2307 Pax6 single+). Blue is DAPI coun-
terstain.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S5.jpeg]
Additional data File 6
Misexpression of Zac1 in the retina does not affect amacrine cells genesis. 
(a-f) P0 retinae were electroporated with control pCIG2 (a,c,e) or 
pCIG2-Zac1 (b,d,f) and cultured 8DIV. Electroporated cells were 
detected by GFP epifluorescence (green; a,b) and amacrine cells were 
identified by anti- syntaxin (red; c,d). (e,e',f,f') Merged images show sim-
ilar numbers of GFP-positive electroporated cells that expressed syntaxin 
(Syn) after control (e) and Zac1 (f) electroporations. Arrowheads indi-
cate electroporated cells that differentiated into amacrine cells. e' and f' 
are high magnification images of boxed area in e and f. (g) Quantitation 
of the percentage of electroporated cells that differentiate into amacrine 
cells after control pCIG2 (black bar; n = 3) or pCIG2-Zac1 (white bar; n 
= 3) electroporations. pCIG2 at E15.5: 62.3 ± 6.5%; 519 syntaxin/GFP 
double+/787 GFP+; Zac1 at E15.5: 72.7 ± 5.4%; 379 syntaxin/GFP dou-
ble+/680 GFP+; pCIG2 at E17.5: 39.3 ± 5.4%; 897 syntaxin/GFP dou-
ble+/2520 GFP+; Zac1 at E17.5: 51.3 ± 2.0%; 456 syntaxin/GFP 
double+/928 GFP+; pCIG2 at P0: 11.7 ± 3.4%; 81 syntaxin/GFP dou-
ble+/552 GFP+; Zac1 at P0: 10.2 ± 2.3%; 83 syntaxin/GFP double+/376 
GFP+.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S6.jpeg]
Additional data File 7
Molecular profile of Zac1-deficient retinal progenitors is unperturbed at 
E18.5. RNA in situ hybridization of E18.5 wild-type (non-prime) and 
Zac1-deficient (prime) retinae with Hes5 (a,a'), Hes1 (b,b'), Rx (c,c'), 
Chx10 (d,d'), Crx (e,e'), Barhl2 (f,f'), Mash1 (g,g'), Foxn4 (h,h'), 
NeuroD (i,i'), Math3 (j,j'), Math5 (k,k') and Pax6 (l,l') probes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-
8104-2-11-S7.jpeg]Page 19 of 21
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